Novel conditionally active T cell engagers sourced from proprietary BiTAC® platform are at the basis of advanced partnering initiatives and development activities ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal compression-related false lows from true blood glucose lows - ...

Biotechnology investors often focus on clinical milestones, regulatory approvals, and commercial launches. Yet in antibody ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Pierre-Alain Ruffieux of Cytiva discusses key biotech trends including new modalities, AI adoption, supply chain stability, ...

GEA has moved its Application and Technology Center (ATC) for New Food and biotechnology from Hildesheim to Sarstedt in Lower Saxony, Germany, investing €4 ...

The startup is focused on developing evidence-based natural and synthetic therapeutics for conditions such as psoriasis, ...

Financial research published in the BMJ shows the trade deal could end up costing the NHS tens of billions.

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

Tsingke Biotech recently hosted the Oligonucleotide Drug Salon at the Hilton Shanghai Zhangjiang, bringing together experts ...